{"id":403732,"date":"2025-07-15T13:30:00","date_gmt":"2025-07-15T11:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/glp-1ra-em-mash-o-que-ha-de-novo\/"},"modified":"2025-07-15T08:37:23","modified_gmt":"2025-07-15T06:37:23","slug":"glp-1ra-em-mash-o-que-ha-de-novo","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/glp-1ra-em-mash-o-que-ha-de-novo\/","title":{"rendered":"GLP-1RA em MASH &#8211; o que h\u00e1 de novo?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>A esteato-hepatite associada \u00e0 disfun\u00e7\u00e3o metab\u00f3lica (MASH) corresponde<br\/>\u00e0 doen\u00e7a hep\u00e1tica anteriormente conhecida como inflama\u00e7\u00e3o hep\u00e1tica gorda n\u00e3o alco\u00f3lica (NASH). As causas mais comuns da MASH s\u00e3o a obesidade e a diabetes. Ainda n\u00e3o existem medicamentos especificamente autorizados neste pa\u00eds, pelo que a farmacoterapia se centra nas doen\u00e7as metab\u00f3licas associadas. O GLP-1RA semaglutide pode contribuir para uma redu\u00e7\u00e3o da fibrose na MASH, como demonstram os resultados de um estudo atual. Existem tamb\u00e9m dados interessantes sobre o resmetirome e outras subst\u00e2ncias activas.    <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fglp-1ra-em-mash-o-que-ha-de-novo%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>A esteato-hepatite associada \u00e0 disfun\u00e7\u00e3o metab\u00f3lica (MASH) corresponde\u00e0 doen\u00e7a hep\u00e1tica anteriormente conhecida como inflama\u00e7\u00e3o hep\u00e1tica gorda n\u00e3o alco\u00f3lica (NASH). As causas mais comuns da MASH s\u00e3o a obesidade e a&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fglp-1ra-em-mash-o-que-ha-de-novo%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":403744,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Doen\u00e7a hep\u00e1tica esteat\u00f3tica  ","footnotes":""},"category":[11551,11397,11521,11453,11407,11305,11529],"tags":[83721,83716,83714,83708,46429,83723,17379],"powerkit_post_featured":[],"class_list":["post-403732","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-endocrinologia-e-diabetologia-2","category-estudos","category-farmacologia-e-toxicologia","category-gastroenterologia-e-hepatologia","category-medicina-interna-geral","category-relatorios-do-congresso","tag-esteato-hepatite-associada-a-disfuncao-metabolica","tag-glp-1ra-pt-pt","tag-inflamacao-do-figado-gordo-nao-alcoolico","tag-mash-pt-pt-2","tag-nash-pt-pt","tag-reducao-das-fibras","tag-semaglutidea","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-20 02:24:52","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":403735,"slug":"glp-1ra-en-el-mash-que-hay-de-nuevo","post_title":"GLP-1RA en el MASH: \u00bfqu\u00e9 hay de nuevo?","href":"https:\/\/medizinonline.com\/es\/glp-1ra-en-el-mash-que-hay-de-nuevo\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/403732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=403732"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/403732\/revisions"}],"predecessor-version":[{"id":403750,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/403732\/revisions\/403750"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/403744"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=403732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=403732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=403732"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=403732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}